Literature DB >> 2228517

Change in the role of the spleen from protective to harmful following tumor progression in AKR lymphoma.

J Leibovici1, M Michowitz, H Argaman.   

Abstract

Tumor progression has been reported to be often accompanied by a loss of sensitivity to various elements of the immune system. In the present study, three variants of malignancy of AKR lymphoma were compared as to the host reaction they elicit. Splenectomy caused an acceleration of growth of the low-metastasizing tumor, slightly inhibited the growth of the tumor of intermediate malignancy and significantly inhibited the development of the high-metastasizing lymphoma. These results suggest that splenic elements exert an inhibitory effect on the low-metastasizing tumor and a growth-stimulatory effect on the more malignant ones. While decreased sensitivity to various host defense mechanisms following tumor progression has been amply documented, the present study shows a more severe phenomenon: increased malignancy can be accompanied by a deviation of the host immune reaction from tumor growth inhibition to growth stimulation.

Entities:  

Mesh:

Year:  1990        PMID: 2228517

Source DB:  PubMed          Journal:  Invasion Metastasis        ISSN: 0251-1789


  4 in total

1.  The paradoxical effects of splenectomy on tumor growth.

Authors:  Richmond T Prehn
Journal:  Theor Biol Med Model       Date:  2006-06-26       Impact factor: 2.432

2.  The role of the spleen in the organ-specific metastasis of murine BW 5147 T lymphomas.

Authors:  C Schmidt; H Verschueren; D Toussaint-Demylle; T van den Berg; G Kraal; P De Baetselier
Journal:  Clin Exp Metastasis       Date:  1994-03       Impact factor: 5.150

3.  Comparison of splenectomy effects as an indication for host response to growth of primary and metastatic tumour cells in two murine tumour systems.

Authors:  M Michowitz; N Donin; J Sinai; J Leibovici
Journal:  Int J Exp Pathol       Date:  1995-02       Impact factor: 1.925

4.  Splenectomy before tumor inoculation prolongs the survival time of cachectic mice.

Authors:  K Soda; M Kawakami; S Takagi; A Kashii; M Miyata
Journal:  Cancer Immunol Immunother       Date:  1995-10       Impact factor: 6.968

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.